UK markets are bracing for a defensive session as hotter-than-expected inflation data reshapes the outlook for Bank of England monetary policy this Thursday.
Headline CPI came in at 3.5% for September, while core inflation climbed to 2.8%, marking a six-month high that exceeded analyst forecasts.
Factory gate prices rose 4.6% year on year and 0.8% month on month, keeping the near-term inflation story firmly in focus for investors.
Higher core prices and rising producer costs point to stickier domestic inflation, which can keep gilt yields under upward pressure and lift borrowing costs for households and companies.
That combination complicates earnings planning for rate-sensitive sectors and squeezes valuation support where financing needs are heaviest.
The open question is how the Bank of England weighs this firmer inflation backdrop against already soft business sentiment and upcoming UK confidence data.
Quilter reported a 30% rise in core net inflows in Q3 to £2.9 billion, with assets under management and administration reaching £160.5 billion, while platform net inflows were 25% higher year on year.
SEGRO (SGRO) posted £70 million of new headline rent contracted year to date, with occupancy at 94.7% and customer retention at 80%, alongside a UK big box joint venture expected to raise around £500 million in net proceeds.
GSK (GSK) gained worldwide rights outside China and parts of Asia to HUTCHMED’s HMPL-A830 cancer therapy, with upfront, milestone, and royalty payments tied to development progress.
GSK also highlighted five-year real-world data on HIV treatment Cabenuva, where 77% of patients in the OPERA study stayed on therapy with sustained viral suppression.
Among top movers, Ashtead Technology Holdings (LSE: AT.) surged 14.72% after traders focused on its exposure to subsea services and equipment demand across the energy sector.
Watches of Switzerland Group (LSE: WOSG) climbed 5.31% as RBC reiterated its sector perform rating and 800p price target on the luxury watch retailer.
On the downside, Halfords Group (LSE: HFD) fell 8.63% as investors reacted to heavier second-half investment plans, despite the company maintaining its profit guidance for the year.
Aberdeen Group (LSE: ABDN) declined 4.09% following its Q3 update on higher assets and inflows, while 3i Group (LSE: III) dropped 3.93%.
Barclays is due to report Q3 results on Thursday, with net interest income and provisions in sharp focus given UK CPI at 3.5% and elevated gilt yields affecting funding costs.
J Sainsbury also reports first-half numbers Thursday, with like-for-like sales and profit margins under the microscope as households juggle 3.5% inflation against 3.7% total pay growth.
The CBI Business Optimism Index previously printed at 36, and a weaker Q4 reading than the forecast 38 would underline the squeeze from higher producer prices on UK manufacturing investment appetite.
UK Retail Sales data due Friday carries a consensus of a 0.1% monthly decline and 1% annual rise, making any upside a signal that consumers are absorbing wage growth without sharply cutting discretionary spending.
Energy has held firm as Brent crude trades above $110, with the UK government signing off new North Sea projects including Shell’s Jackdaw gas field, offering cash flow support for domestic producers.
The Healthcare sector has edged higher this week as GSK’s new licensing deal and supportive HIV data on Cabenuva highlight how large drug groups can refresh their pipelines beyond in-house research alone.
